He will report to Mark Epley and Mike Hill, Co-Heads of Corporate Finance for the Americas, and will be responsible for leading the firm’s coverage of healthcare companies operating in the United States while working with colleagues in Japan, AEJ and EMEA to deliver cross-regional opportunities.
“Jason brings a tremendous amount of transactional experience and deep client relationships to Nomura at a time when the firm is seeing a significant increase in cross border M&A and financing activity.” said Jim DeNaut, Head of Investment Banking for the Americas and Joint International Head of Investment Banking at Nomura. “Jason’s experience working with clients in Japan will be a significant benefit to our franchise. His appointment to this newly created role demonstrates Nomura’s twin-track strategy of focusing on its considerable strengths in the Americas, while allocating resources to increase cross-regional collaboration across the firm.”
Jason has more than 15 years of investment banking experience, focused principally on the pharmaceutical and medical technology sectors, and has advised clients on $50bn+ of strategic and financing transactions. He started his investment banking career at Lehman Brothers where he joined the global healthcare investment banking group in New York in 1998 and has led investment banking coverage of the specialty pharmaceutical sector at Barclays Capital and Lehman. Nomura’s Wholesale operations in the Americas recently reported its strongest quarterly revenues. The firm’s Investment Banking franchise is continually building on its proven track record as a provider of strategic and financing solutions to individual, institutional, corporate and government clients in the Americas and overseas.
